Abstract
Leishmaniasis is an endemic disease in more than 100 countries, with over one million new cases annually. Among Latin American countries, Brazil stands out with higher disease rates, accounting for 96% of visceral leishmaniasis cases (WHO, 2018). Additionally, Leishmania amazonensis is among the circulating species in Brazil and is mainly associated with cutaneous and mucocutaneous manife…